Frederique Menzaghi Ph.D., Senior VP-Research & Development at Cara Therapeutics, Inc. (CARA), sold 2,200 shares at $17.50 ($39K) on 2019-02-25, disclosed to the SEC on 2019-02-27.
Scheduled sale ($38k) by Senior VP-Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CARA | SELL | 2023-03-07 | $132K | — | Filing → |
| CARA | SELL | 2022-12-23 | $40K | — | Filing → |
| CARA | SELL | 2022-04-05 | $21K | — | Filing → |